In the wake of new research indicating increased risks of heart attacks and strokes, the FDA is requiring new warning labels for nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, which Read More
In the wake of new research indicating increased risks of heart attacks and strokes, the FDA is requiring new warning labels for nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, which Read More